Tilray: Difference between revisions

Latest revision as of 10:53, 15 February 2025

Canadian pharmaceutical and cannabis company

The logo of Tilray Brands

Tilray, Inc. is a Canadian pharmaceutical and cannabis company, headquartered in Nanaimo, British Columbia. It is one of the largest and most well-known companies in the cannabis industry, involved in the research, cultivation, processing, and distribution of cannabis and cannabis-derived products.

History[edit]

Tilray was founded in 2013 and quickly became a prominent player in the cannabis market. The company was one of the first to receive a license from Health Canada to produce medical cannabis. In 2018, Tilray became the first cannabis company to have an initial public offering (IPO) on the NASDAQ stock exchange, marking a significant milestone in the cannabis industry.

Operations[edit]

Tilray operates in several countries, including Canada, the United States, Germany, Portugal, and Australia. The company focuses on the production of high-quality medical cannabis products, including dried flower, oils, and capsules. Tilray also engages in extensive research and development to explore the potential therapeutic benefits of cannabis.

Research and Development[edit]

Tilray invests heavily in research and development to advance the understanding of cannabis and its potential medical applications. The company collaborates with leading academic institutions and research organizations to conduct clinical trials and studies on the efficacy and safety of cannabis-based treatments.

Global Expansion[edit]

Tilray has expanded its operations globally, establishing production facilities and partnerships in various countries. In Portugal, Tilray operates a state-of-the-art cultivation and processing facility, which serves as a hub for its European operations. The company also has strategic partnerships in the United States to enhance its presence in the rapidly growing American cannabis market.

Products[edit]

Tilray offers a wide range of cannabis products, catering to both medical and recreational markets. These products include:

Dried Cannabis: High-quality dried cannabis flower available in various strains.
Cannabis Oils: Concentrated cannabis oils for oral consumption.
Capsules: Pre-measured cannabis capsules for precise dosing.
Edibles and Beverages: A variety of cannabis-infused edibles and beverages.

Corporate Social Responsibility[edit]

Tilray is committed to corporate social responsibility and sustainability. The company implements environmentally friendly practices in its cultivation and production processes. Tilray also engages in community outreach and supports initiatives aimed at promoting the responsible use of cannabis.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Tilray''' is a global pioneer in the research, cultivation, production, and distribution of [[cannabis]] and cannabinoids. The company was founded in 2013 with a focus on leveraging the medicinal benefits of cannabis to improve health and well-being. Tilray has grown to become one of the leading players in the cannabis industry, with operations spanning multiple countries across the globe.
+{{short description|Canadian pharmaceutical and cannabis company}}
+{{Use Canadian English|date=October 2023}}
+{{Use dmy dates|date=October 2023}}
+[[File:Tilray Brands Logo.png|thumb|right|The logo of Tilray Brands]]
+'''Tilray, Inc.''' is a Canadian pharmaceutical and [[cannabis]] company, headquartered in [[Nanaimo]], [[British Columbia]]. It is one of the largest and most well-known companies in the [[cannabis industry]], involved in the research, cultivation, processing, and distribution of cannabis and cannabis-derived products.
 ==History==
-Tilray was established in 2013, initially focusing on medicinal cannabis. It was one of the first companies to be licensed by Health Canada to produce and sell medical cannabis in Canada. Over the years, Tilray has expanded its operations beyond Canada, entering markets in Europe, Australia, Latin America, and the United States. The company has been at the forefront of clinical research on cannabis, partnering with hospitals, universities, and governments to better understand the medicinal properties of cannabis and to develop new cannabis-derived pharmaceuticals.
+Tilray was founded in 2013 and quickly became a prominent player in the cannabis market. The company was one of the first to receive a license from [[Health Canada]] to produce medical cannabis. In 2018, Tilray became the first cannabis company to have an initial public offering (IPO) on the [[NASDAQ]] stock exchange, marking a significant milestone in the cannabis industry.
 ==Operations==
-Tilray's operations are diverse, covering the cultivation of cannabis in state-of-the-art facilities, the production of cannabis products, and research and development into new cannabis-based medicines. The company's product portfolio includes dried cannabis, cannabis oils, and capsules, which are available for both medicinal and recreational use, depending on the legal status of cannabis in different jurisdictions.
+Tilray operates in several countries, including [[Canada]], the [[United States]], [[Germany]], [[Portugal]], and [[Australia]]. The company focuses on the production of high-quality medical cannabis products, including dried flower, oils, and capsules. Tilray also engages in extensive research and development to explore the potential therapeutic benefits of cannabis.
-===Cultivation===
+===Research and Development===
-Tilray operates several cultivation sites around the world, employing advanced agricultural technologies to ensure the production of high-quality cannabis. These facilities are designed to control every aspect of the growing environment, from temperature and humidity to light and nutrition, ensuring that the cannabis plants grow under optimal conditions.
+Tilray invests heavily in [[research and development]] to advance the understanding of cannabis and its potential medical applications. The company collaborates with leading academic institutions and research organizations to conduct clinical trials and studies on the efficacy and safety of cannabis-based treatments.
-===Research and Development===
+===Global Expansion===
-A significant part of Tilray's operations is dedicated to research and development. The company collaborates with external partners, including universities and hospitals, to conduct clinical trials and studies on the efficacy of cannabis and cannabinoids in treating various medical conditions. This research is critical for developing new cannabis-based pharmaceuticals and for gaining regulatory approval for these products.
+Tilray has expanded its operations globally, establishing production facilities and partnerships in various countries. In [[Portugal]], Tilray operates a state-of-the-art cultivation and processing facility, which serves as a hub for its European operations. The company also has strategic partnerships in the United States to enhance its presence in the rapidly growing American cannabis market.
-==Market and Products==
+==Products==
-Tilray serves both the medicinal and recreational cannabis markets. Its medicinal cannabis products are designed for patients who require cannabis for treatment of specific health conditions, such as chronic pain, epilepsy, and multiple sclerosis. For the recreational market, Tilray offers a range of cannabis strains and products designed for adult use, where legal.
+Tilray offers a wide range of cannabis products, catering to both medical and recreational markets. These products include:
-==Regulatory Environment==
+* '''Dried Cannabis''': High-quality dried cannabis flower available in various strains.
-The legal landscape for cannabis varies significantly from country to country, and Tilray operates within the regulatory frameworks of each jurisdiction. In Canada, Tilray was one of the beneficiaries of the federal legalization of cannabis for recreational use in 2018. In other countries, the company navigates a complex patchwork of laws governing medicinal cannabis.
+* '''Cannabis Oils''': Concentrated cannabis oils for oral consumption.
+* '''Capsules''': Pre-measured cannabis capsules for precise dosing.
+* '''Edibles and Beverages''': A variety of cannabis-infused edibles and beverages.
-==Challenges and Opportunities==
+==Corporate Social Responsibility==
-The cannabis industry faces numerous challenges, including regulatory hurdles, market volatility, and competition. However, Tilray has positioned itself as a leader in the industry, with a strong focus on research, quality, and compliance. The ongoing global trend towards the legalization of cannabis for medicinal and recreational use presents significant opportunities for Tilray to expand its operations and market reach.
+Tilray is committed to corporate social responsibility and sustainability. The company implements environmentally friendly practices in its cultivation and production processes. Tilray also engages in community outreach and supports initiatives aimed at promoting the responsible use of cannabis.
-==Conclusion==
+==Related pages==
-Tilray's journey from a medicinal cannabis startup to a global leader in the cannabis industry highlights the growing acceptance of cannabis and cannabinoids for medicinal and recreational use. Through its commitment to research, quality, and compliance, Tilray is well-positioned to continue its growth and to play a significant role in shaping the future of the cannabis industry.
+* [[Cannabis in Canada]]
+* [[Medical cannabis]]
+* [[Cannabis industry]]
+* [[Pharmaceutical industry]]
-[[Category:Cannabis companies]]
+[[Category:Cannabis companies of Canada]]
+[[Category:Pharmaceutical companies of Canada]]
+[[Category:Companies based in British Columbia]]
 [[Category:Companies established in 2013]]
-{{pharma-stub}}